Carina Lemke
Research Subjects
Carina Lemke has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alexey Simakov
Université Marie et Louis Pasteur, INSERM UMR1322 LINC, F-25000 Besançon, France
1 shared publication - Anna Novotna
Pharmaceutical Institut, An der Immenburg 4, D-53121 Bonn, Germany
1 shared publication - Hélène Martin
Université de Franche-Comté, EFS, INSERM, UMR RIGHT, F-25000 Besançon, France
1 shared publication - Irene Pachòn Angona
Neurosciences Intégratives et Cliniques EA 481, Pôle de Chimie Organique et Thérapeutique, Univ. Bourgogne Franche-Comté, UFR Santé, 19, rue Ambroise Paré, F-25000 Besançon, France
1 shared publication - José Marco-Contelles
Institute of General Organic Chemistry (CSIC), C/Juan de la Cierva 3, 28006 Madrid, Spain
1 shared publication - Krzysztof Jozwiak
Department of Biopharmacy, Medical University of Lublin, Lublin, Poland
1 shared publication
Latest Publications
- Open Access
- 17 January 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (1) , 121
Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca2+ Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties
This work relates to the design and synthesis of a series of novel multi-target directed ligands (MTDLs), i.e., compounds 4a–l, via a convenient one-pot three-component Hantzsch reaction. This approach targeted calcium channel antagonism, antioxidant capacity, cathepsin S inhibition, and interference with Nrf2 transcriptional activation. Of these MTDLs, 4i emerged as a promising compound, demonstrating robust antioxidant activity, the ability to activate Nrf2-ARE pathways, as well as calcium channel blockade and cathepsin S inhibition. Dihydropyridine 4i represents the first example of an MTDL that combines these biological activities.
- 17 January 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (1) , 121
Open AccessDesign and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca2+ Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties
This work relates to the design and synthesis of a series of novel multi-target directed ligands (MTDLs), i.e., compounds 4a–l, via a convenient one-pot three-component Hantzsch reaction. This approach targeted calcium channel antagonism, antioxidant capacity, cathepsin S inhibition, and interference with Nrf2 transcriptional activation. Of these MTDLs, 4i emerged as a promising compound, demonstrating robust antioxidant activity, the ability to activate Nrf2-ARE pathways, as well as calcium channel blockade and cathepsin S inhibition. Dihydropyridine 4i represents the first example of an MTDL that combines these biological activities.